🇺🇸 FDA
Patent

US 9775895

HIV therapeutics and methods of making and using same

granted A61KA61K2039/5258A61K2039/575

Quick answer

US patent 9775895 (HIV therapeutics and methods of making and using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/5258, A61K2039/575, A61K2039/64, A61K39/12